Taught course

Manufacture and Commercialisation of Stem Cell and Gene Therapies MSc

Institution
UCL - University College London · Biochemical Engineering
Qualifications
MSc

Visit the institution website for COVID‑19 updates

Entry requirements

A minimum of an upper second-class Bachelor's degree in relevant subject (e.g. Life Sciences, Biotechnology, Bioengineering, Environmental Science, Engineering, Chemistry or Business with a Biotechnology component) from a UK university or the equivalent from an approved overseas institution. Candidates offering recent industrial experience are also encouraged to apply.

If your education has not been conducted in the English language, you will be expected to demonstrate evidence of an adequate level of English proficiency.

The English language level for this programme is: Good.

Further information can be found on our English language requirements page.

Pre-Master's and Pre-sessional English

UCL Pre-Master's and Pre-sessional English courses are for international students who are aiming to study for a postgraduate degree at UCL. The courses will develop your academic English and academic skills required to succeed at postgraduate level. International Preparation Courses

Months of entry

September

Course content

Rapid developments in the stem cell and gene therapy field have created skills shortages in this high-value manufacturing sector. This innovative and industrially-relevant MSc, which is co-developed and co-delivered by industry experts, provides key skills, practical training and expertise to develop future generations of engineers, scientists and business professionals with the breadth and depth required to manufacture and deliver 21st century medicines.

Fees and funding

Please see UCL website for full information about fees and costs for this programme.

Qualification, course duration and attendance options

  • MSc
    full time
    12 months
    • Campus-based learningis available for this qualification

Course contact details

Phone
+44 (0) 20 3370 1214